Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 19/20 | 0.79 |
| ▸ | CDK12 | Q9NYV4 | 19/20 | 0.79 |
| ▸ | CCNT1 | O60563 | 17/20 | 0.79 |
| ▸ | CDK9 | P50750 | 17/20 | 0.79 |
| ▸ | CCNE1 | P24864 | 15/20 | 0.79 |
| ▸ | CDK2 | P24941 | 15/20 | 0.79 |
| ▸ | CDK7 | P50613 | 10/20 | 0.75 |
| ▸ | CCNH | P51946 | 10/20 | 0.75 |
| ▸ | MNAT1 | P51948 | 7/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30204442 | 0.88 | CCNK (1.00) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL24839376 | 0.88 | CCNK (1.00) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL25597608 | 0.87 | CCNK (0.75) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL24839829 | 0.86 | CCNK (1.00) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL24839783 | 0.86 | CCNK (1.00) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL26738531 | 0.85 | CCNK (0.80) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL24588249 | 0.84 | CCNK (0.80) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL25593281 | 0.84 | CCNK (0.77) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30260995 | 0.83 | CCNT1 (0.95) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL30439811 | 0.83 | CCNK (1.00) | CCNKCDK12CCNT1CDK9CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4186895-A1 | COMPOUND USEFUL AS CDK7 KINASE INHIBITOR AND USE THEREOF | TYK Medicines Inc. (CN) | 2023-05-31 | — | — | EP | disclosed |